CYPRESS BIOSCIENCE INC 4

Accession 0000716054-04-000036

CIK 0000716054operating

View on SEC.gov Company Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 6:04 PM ET

Size

38.8 KB

Accession

0000716054-04-000036

Insider Transaction Report

Form 4

Period: 2004-12-02

CYPRESS BIOSCIENCE INCCYPB

GENDREAU R MICHAEL

Chief Medical Officer

Transactions

Exercise/Conversion
Stock Option (right to buy)
2004-12-02−3,125→ 0 total
Exercise: $2.50From: 1996-04-29Exp: 2006-04-29→ Common Stock (3,125 underlying)
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−10,000→ 0 total
Exercise: $2.50From: 1996-04-29Exp: 2006-04-29→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2004-12-02$2.50/sh+3,125$7,813→ 7,725 total
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−7,045→ 688 total
Exercise: $3.25From: 2004-04-29Exp: 2012-04-29→ Common Stock (7,045 underlying)
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−2,100→ 0 total
Exercise: $2.50From: 1995-03-31Exp: 1999-01-31→ Common Stock (2,100 underlying)
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−12,423→ 731 total
Exercise: $2.51From: 2003-03-27Exp: 2013-03-27→ Common Stock (12,423 underlying)
Exercise/Conversion
Common Stock
2004-12-02$2.50/sh+2,100$5,250→ 2,100 total
Exercise/Conversion
Common Stock
2004-12-02$2.50/sh+4,824$12,060→ 30,026 total
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−2,500→ 0 total
Exercise: $2.50From: 1996-04-29Exp: 2006-04-29→ Common Stock (2,500 underlying)
Exercise/Conversion
Common Stock
2004-12-02$1.41/sh+9,833$13,827→ 39,859 total
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−9,833→ 0 total
Exercise: $1.41From: 2001-03-20Exp: 2011-03-20→ Common Stock (9,833 underlying)
Exercise/Conversion
Common Stock
2004-12-02$2.50/sh+2,500$6,250→ 4,600 total
Exercise/Conversion
Common Stock
2004-12-02$2.50/sh+10,000$25,000→ 17,725 total
Exercise/Conversion
Common Stock
2004-12-02$2.50/sh+7,477$18,693→ 25,202 total
Exercise/Conversion
Common Stock
2004-12-02$2.51/sh+12,423$31,182→ 52,282 total
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−4,824→ 0 total
Exercise: $2.50From: 1998-08-10Exp: 2006-06-27→ Common Stock (4,824 underlying)
Exercise/Conversion
Stock Option (right to buy)
2004-12-02−7,477→ 0 total
Exercise: $2.50From: 1998-08-10Exp: 2006-06-27→ Common Stock (7,477 underlying)
Exercise/Conversion
Common Stock
2004-12-02$3.25/sh+7,045$22,896→ 59,327 total
Sale
Common Stock
2004-12-02$12.56/sh−59,327$745,082→ 0 total

Footnotes (7)

[F1]The shares subject to the option vested daily and ratably over a period of four years beginning March 31, 1995, and as of January 31, 1999, were fully vested.
[F2]The shares subject to the option vested 100% as of April 29, 1996.
[F3]The shares subject to the option vested daily and ratably over a period of four years beginning April 29, 1996, and as of April 29, 1999, were fully vested.
[F4]The shares subject to the option began vesting August 10, 1998, and as of February 10, 2002, were fully vested.
[F5]The shares subject to the option began vesting March 21, 2001, and as of December 31, 2002, were fully vested.
[F6]The shares subject to the option began vesting March 27, 2003, and as of December 1, 2003, 12,423 were fully vested with the remaining 731 options vesting daily and ratably until fully vested as of December 31, 2004.
[F7]The shares subject to the option vest daily and ratably over a period of two years beginning April 29, 2004

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

CYPRESS BIOSCIENCE INC

CIK 0000716054

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000716054

Filing Metadata

Form type: 4
Filed: Dec 2, 7:00 PM ET
Accepted: Dec 3, 6:04 PM ET
Size: 38.8 KB

View on SEC.gov